The Prognostic Value of Methylation Signatures and NF2 Mutations in Atypical Meningiomas (original) (raw)
Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus
macro mark
BMC Genomics, 2007
View PDFchevron_right
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
Andreas Unterberg
The Lancet. Oncology, 2017
View PDFchevron_right
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
David Raleigh
Nature Genetics
View PDFchevron_right
DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade
Anna-Maria Barciszewska
Journal of Cancer Research and Clinical Oncology, 2015
View PDFchevron_right
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets
Stefania Bartolini
Diagnostics, 2021
View PDFchevron_right
Genetic and epigenetic alterations in meningiomas
Evangeli Lampri
Clinical Neurology and Neurosurgery, 2017
View PDFchevron_right
Meningioma epigenetic grouping reveals biologic drivers and therapeutic vulnerabilities
David Raleigh
2020
View PDFchevron_right
Epigenetics of Meningiomas
László Bognár
BioMed Research International, 2015
View PDFchevron_right
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma
Annika Wefers
Acta Neuropathologica, 2019
View PDFchevron_right
Meningioma: A Pathology Perspective
Kristin Huntoon
Neurosurgery, 2021
View PDFchevron_right
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence
Leah Katz
Acta neuropathologica
View PDFchevron_right
Pathodiagnostic parameters and evaluation of O6– methyl guanine methyl transferase gene promoter methylation in meningiomas
sima afsharnezhad
Gene, 2014
View PDFchevron_right
The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications
Sagar Vasandani
Journal of Neuro-oncology, 2021
View PDFchevron_right
Genetic/molecular alterations of meningiomas and the signaling pathways targeted
Alberto Orfao
Oncotarget, 2015
View PDFchevron_right
Molecular Biological Determinations of Meningioma Progression and Recurrence
Stefan Linsler
PLoS ONE, 2014
View PDFchevron_right
Genomic Analysis of Non- NF2 Meningiomas Reveals Mutations in TRAF7 , KLF4 , AKT1 , and SMO
Yasar Bayri
Science, 2013
View PDFchevron_right
Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms
Steven Giannotta
Neurosurgical focus, 2011
View PDFchevron_right
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1
C. Herold-mende
Acta Neuropathologica, 2020
View PDFchevron_right
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated
Annika Wefers
Journal of Clinical Oncology, 2021
View PDFchevron_right
MOLECULAR GENETICS OF MENINGIOMAS: FROM BASIC RESEARCH TO POTENTIAL CLINICAL APPLICATIONS TOPIC REVIEW
Kevin Gunawan
View PDFchevron_right
EPCO-40. Infratentorial NF2 Mutant Sporadic Meningiomas Differ from Those in Supratentorial Locations and Are More Benign
Sagar Vasandani
Neuro-Oncology
View PDFchevron_right
NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas
Juan Carlos Rey, Ph.D.
Oncogene, 1999
View PDFchevron_right
Aggressive Phenotypic and Genotypic Features in Pediatric and NF2-Associated Meningiomas: A Clinicopathologic Study of 53 Cases
David Gutmann
Journal of Neuropathology & Experimental Neurology, 2001
View PDFchevron_right
DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q
Manuel Gutierrez
Acta Neuropathologica, 2004
View PDFchevron_right
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
Burçin Baran
Nature communications, 2017
View PDFchevron_right
The Loss of 1p as a Reliable Marker of Progression in a Child with Aggressive Meningioma: A 16-Year Follow-Up Case Report
Joachim Oertel
Pediatric Neurosurgery, 2020
View PDFchevron_right
NF2 gene expression in sporadic meningiomas: Relation to grades or histotypes real time-PCR study
Gian Luigi Taddei
Neuropathology, 2007
View PDFchevron_right